advertisement
11.1 General management, indication (9)
Showing records 1 to 9
Display all abstracts in classification 11.1 General management, indication
Search within classification 11.1 General management, indication10571 The circadian effects of antiglaucomatous drugs
Bron A
Journal Français d'Ophtalmologie 2004; 27, Hors série 2: 2S33-2S38
10609 How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications
De Natale R; Draghi E; Dorigo MT
Acta Ophthalmologica Scandinavica 2004; 82: 393-6
10614 Circadian rhythm variations of intraocular pressure and therapeutic decisions: interpretation of clinical trial results based on a statistical model
Denis P; Berdeaux G
Journal Français d'Ophtalmologie 2004; 27, Hors série 2: 2S39-2S43
10613 Medical outcomes of glaucoma therapy from a nationwide representative survey
Denis P; Lafuma A; Berdeaux G
Clinical Drug Investigation 2004; 24: 343-352
10671 The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals
Higginbotham EJ; Gordon MO; Beiser JA; Drake MV; Bennett GR; Wilson MR; Kass MA; Ocular Hypertension Treatment Study Group
Archives of Ophthalmology 2004; 122: 813-20
10673 Inhibitory effects of anti-glaucoma drugs on corneal epithelial migration in a rabbit organ culture system
Hirano S; Sagara T; Suzuki K; Seki K; Nishida T
Journal of Glaucoma 2004; 13: 196-9
10708 Antiglaucoma eye drop pulses--increased interleukin-6 secretion by Tenon's capsule fibroblast cultures
Koh SW; Coll TJ; Rose L; Matsumoto Y; Higginbotham EJ
Journal of Glaucoma 2004; 13: 200-9
10789 Corneal and conjunctival changes caused by commonly used glaucoma medications
Noecker RJ; Herrygers LA; Anwaruddin R
Cornea 2004; 23: 490-496
10915 Inhibition of endothelin-1 and KC1-induced increase of [Ca 2+]i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells
Wu K-Y; Wang H-Z; Hong S-J
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 201-209
